For Pharma, Trump vs. Harris Is a Showdown Between Two Industry Foes - KFF Health News
Source: KHN
Former President Donald Trump and Vice President Kamala Harris have a rare point of agreement in their otherwise bitter and divisive contest: It’s up to the government to cut high U.S. drug prices. Harris cast the tie-breaking Senate vote in 2022 for legislation that allows Medicare to negotiate drug prices for its more than 60 million beneficiaries. Before that, she was an aggressive regulator of the drug…
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at KHN